A new analysis in CMAJ (Canadian Medical Association Journal) www.cmaj.ca/lookup/doi/10.1503/cmaj.180897 outlines the potential government cost of a national Canadian pharmacare program and sets out approaches to shifting the funding for drugs in Canada to realize billions in savings. “We believe there is a compelling argument for the federal government to raise the incremental revenues needed […]